Ding Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ding Yang has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
- Xing Wei
Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
9 shared publications - Qiang Li
Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China
8 shared publications - Qiuling Shi
School of Public Health, Chongqing Medical University, Chongqing, People’s Republic of China
8 shared publications - Wei Dai
Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China
8 shared publications - Hongfan Yu
Department of Pharmacy, The First Affiliated Hospital of Army Medical University, Third Military Medical University, Chongqing, China
6 shared publications - Yangjun Liu
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
6 shared publications
Latest Publications
- 10 February 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (5) , 4288-4300
Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study
The purpose of this study was to compare patient-reported outcomes (PROs) and perioperative clinical outcomes during 1 year post surgery between robot-assi
- 10 February 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (5) , 4288-4300
Long-Term Patient-Reported Outcomes after Multiport Robot-Assisted Surgery versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study
The purpose of this study was to compare patient-reported outcomes (PROs) and perioperative clinical outcomes during 1 year post surgery between robot-assi
- 9 February 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (5) , 4360-4361
ASO Visual Abstract: Long-Term Patient-Reported Outcomes After Multiport Robot-Assisted Surgery Versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study
- 9 February 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (5) , 4360-4361
ASO Visual Abstract: Long-Term Patient-Reported Outcomes After Multiport Robot-Assisted Surgery Versus Video-Assisted Surgery for Lung Cancer: An Observational Cohort Study
- Open Access
- 6 February 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Days alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study
This study aimed to provide Chinese data on Days Alive and Out of Hospital (DAOH) following video-assisted thoracoscopic surgery (VATS) lobectomy or segmen
- 6 February 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Open AccessDays alive and out of hospital after video-assisted thoracoscopic lobectomy or segmentectomy for lung cancer: a prospective Chinese cohort study
This study aimed to provide Chinese data on Days Alive and Out of Hospital (DAOH) following video-assisted thoracoscopic surgery (VATS) lobectomy or segmen
- Open Access
- 29 December 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (4) , 2834-2836
Expanding Surgical Boundaries in Pseudomyxoma Peritonei: The Emerging Role of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy for Pleural Metastases
- 29 December 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (4) , 2834-2836
Open AccessExpanding Surgical Boundaries in Pseudomyxoma Peritonei: The Emerging Role of Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy for Pleural Metastases
- Open Access
- 8 May 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (9) , 5410-5418
Balancing precision and quality of life: Comparing systematic lymph node dissection and sampling in early-stage NSCLC through patient-reported outcomes
- 8 May 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 48 (9) , 5410-5418
Open AccessBalancing precision and quality of life: Comparing systematic lymph node dissection and sampling in early-stage NSCLC through patient-reported outcomes
- Open Access
- 13 December 2024
- Published by Wiley in Thoracic Cancer
- Vol. 16 (1)
Long‐Term Function Recovery Following Upper Versus Lower Lobectomy for Lung Cancer: A Multicenter Longitudinal Cohort Study
Background: The effects of lobectomy at various lung sites on postoperative function and recovery vary. This study aimed at assessing the long‐term impact of upper versus lower lobectomy on patients' postoperative daily function by analyzing patient‐reported outcomes.Methods: This multicenter prospective cohort study enrolled patients from six hospitals in China. Functional impairments and symptom severity were measured using the MD Anderson Symptom Inventory‐Lung Cancer. A mixed‐effects linear model was employed to analyze the average trajectories of each functional item and the top five symptoms over the first year following surgery between patients undergoing upper and lower lobectomy. The median recovery days for daily function were estimated using the Kaplan–Meier method, with the log‐rank test comparing differences between upper and lower lobectomy.Results: Two hundred twenty‐six patients met the final analysis criteria, with 137 undergoing upper and 89 undergoing lower lobectomies. Those in the lower lobectomy group reported significantly greater interference with daily activities (estimate = 0.872, SE = 0.306, p = 0.004), mood (estimate = 0.667, SE = 0.297, p = 0.025), and work (estimate = 0.856, SE = 0.358, p = 0.017), indicating a more pronounced impact on postsurgical functional recovery compared to the upper lobectomy group within the first year after surgery. They also experienced longer median recovery times for daily activities (15 vs. 4 days), mood (6 vs. 3.5 days), and walking (7 vs. 4 days) compared to the upper lobectomy group.Conclusions: Within the first year after surgery, lower lobectomy patients experienced greater impairment in daily functions and required longer recovery times compared to upper lobectomy patients.Trial Registration: NCT03341377
- 13 December 2024
- Published by Wiley in Thoracic Cancer
- Vol. 16 (1)
Open AccessLong‐Term Function Recovery Following Upper Versus Lower Lobectomy for Lung Cancer: A Multicenter Longitudinal Cohort Study
Background: The effects of lobectomy at various lung sites on postoperative function and recovery vary. This study aimed at assessing the long‐term impact of upper versus lower lobectomy on patients' postoperative daily function by analyzing patient‐reported outcomes.Methods: This multicenter prospective cohort study enrolled patients from six hospitals in China. Functional impairments and symptom severity were measured using the MD Anderson Symptom Inventory‐Lung Cancer. A mixed‐effects linear model was employed to analyze the average trajectories of each functional item and the top five symptoms over the first year following surgery between patients undergoing upper and lower lobectomy. The median recovery days for daily function were estimated using the Kaplan–Meier method, with the log‐rank test comparing differences between upper and lower lobectomy.Results: Two hundred twenty‐six patients met the final analysis criteria, with 137 undergoing upper and 89 undergoing lower lobectomies. Those in the lower lobectomy group reported significantly greater interference with daily activities (estimate = 0.872, SE = 0.306, p = 0.004), mood (estimate = 0.667, SE = 0.297, p = 0.025), and work (estimate = 0.856, SE = 0.358, p = 0.017), indicating a more pronounced impact on postsurgical functional recovery compared to the upper lobectomy group within the first year after surgery. They also experienced longer median recovery times for daily activities (15 vs. 4 days), mood (6 vs. 3.5 days), and walking (7 vs. 4 days) compared to the upper lobectomy group.Conclusions: Within the first year after surgery, lower lobectomy patients experienced greater impairment in daily functions and required longer recovery times compared to upper lobectomy patients.Trial Registration: NCT03341377
- Open Access
- 13 November 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (11) , e70201
Comparing the Efficacy of Empirical Anti‐Infective Therapy and Follow‐Up Observation for Newly Diagnosed Pulmonary Ground‐Glass Nodules With Suspected Inflammatory Etiology: A Multicenter Prospective Observational Study Protocol
Background and Aims: The optimal management strategy for newly diagnosed pulmonary ground‐glass nodules (GGNs) with suspected inflammatory etiology remains controversial in clinical practice. Empirical anti‐inflammatory therapy is commonly used, but its efficacy compared with that of follow‐up observation lacks high‐quality evidence. Therefore, this study aims to compare the effectiveness of empirical anti‐infective therapy and follow‐up observation for pulmonary GGNs in real‐world settings.Methods: This study intends to include 254 participants with newly discovered pulmonary ground‐glass opacities (GGOs) suspected to be related to inflammation but without current radiographic features suggestive of malignancy. Antibiotics will be recommended when the doctor considers the GGOs may be infection‐related. Upon enrollment, all participants will be assessed with the Self‐Rating Anxiety Scale (SAS) and divided into either the intervention or observation group. A repeat CT scan and SAS assessment will be conducted with all participants after 1 month ( ± 2 weeks) following the initial discovery of the GGOs. The primary outcome is the participants' response rate at the first follow‐up CT. The secondary outcome is the GGO response rate and total scores of SAS at 1 month after enrollment. A non‐inferiority test will be conducted to compare the outcomes between the two groups.Discussion: To date, the efficacy and necessity of using antibiotics for GGOs suspected to be inflammatory upon primary CT screening remain controversial. This protocol describes the rationale and methodology to address this unmet clinical need using real‐world data, aiming to bridge the gap between clinical guidelines and real‐world practice.Trial Registration: ChiCTR2200056975.
- 13 November 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (11) , e70201
Open AccessComparing the Efficacy of Empirical Anti‐Infective Therapy and Follow‐Up Observation for Newly Diagnosed Pulmonary Ground‐Glass Nodules With Suspected Inflammatory Etiology: A Multicenter Prospective Observational Study Protocol
Background and Aims: The optimal management strategy for newly diagnosed pulmonary ground‐glass nodules (GGNs) with suspected inflammatory etiology remains controversial in clinical practice. Empirical anti‐inflammatory therapy is commonly used, but its efficacy compared with that of follow‐up observation lacks high‐quality evidence. Therefore, this study aims to compare the effectiveness of empirical anti‐infective therapy and follow‐up observation for pulmonary GGNs in real‐world settings.Methods: This study intends to include 254 participants with newly discovered pulmonary ground‐glass opacities (GGOs) suspected to be related to inflammation but without current radiographic features suggestive of malignancy. Antibiotics will be recommended when the doctor considers the GGOs may be infection‐related. Upon enrollment, all participants will be assessed with the Self‐Rating Anxiety Scale (SAS) and divided into either the intervention or observation group. A repeat CT scan and SAS assessment will be conducted with all participants after 1 month ( ± 2 weeks) following the initial discovery of the GGOs. The primary outcome is the participants' response rate at the first follow‐up CT. The secondary outcome is the GGO response rate and total scores of SAS at 1 month after enrollment. A non‐inferiority test will be conducted to compare the outcomes between the two groups.Discussion: To date, the efficacy and necessity of using antibiotics for GGOs suspected to be inflammatory upon primary CT screening remain controversial. This protocol describes the rationale and methodology to address this unmet clinical need using real‐world data, aiming to bridge the gap between clinical guidelines and real‐world practice.Trial Registration: ChiCTR2200056975.
- 26 April 2023
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 71 (08) , 671-679
Patient-Reported Outcome–Based Prediction for Postdischarge Complications after Lung Surgery
Background Patients undergoing lung tumor surgery may experience various complications after discharge from the hospital. Using patient-reported outcomes (PROs), this study attempted to identify relevant indicators of postdischarge complications after lung tumor surgery and develop a predictive nomogram model to evaluate the risk for individual patients. Methods Patients who underwent lung tumor surgery between December 2021 and June 2022 were included in this study. PROs were assessed using the Perioperative Symptom Assessment for Lung Surgery scale and were assessed preoperatively at baseline, on postoperative day 1 (POD1) 1 to POD4, and then weekly until the fourth week. A random forest machine learning prediction model was built to rank the importance of each PRO score of patients on POD1 to POD4. We then selected the top 10 variables in terms of importance for the multivariable logistic regression analysis. Finally, a nomogram was developed. Results PROs, including coughing (POD3 and POD4), daily activity (POD1), and pain (POD1 and POD2), were associated with postdischarge complications in patients undergoing lung tumor surgery. The predictive model showed good performance in estimating the risk of postdischarge complications, with an area under the curve of 0.833 (95% confidence interval: 0.753–0.912), while maintaining good calibration and clinical value. Conclusion We found that PRO scores on POD1 to POD4 were associated with postdischarge complications after lung tumor surgery, and we developed a helpful nomogram model to predict the risk of postdischarge complications.
- 26 April 2023
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 71 (08) , 671-679
Patient-Reported Outcome–Based Prediction for Postdischarge Complications after Lung Surgery
Background Patients undergoing lung tumor surgery may experience various complications after discharge from the hospital. Using patient-reported outcomes (PROs), this study attempted to identify relevant indicators of postdischarge complications after lung tumor surgery and develop a predictive nomogram model to evaluate the risk for individual patients. Methods Patients who underwent lung tumor surgery between December 2021 and June 2022 were included in this study. PROs were assessed using the Perioperative Symptom Assessment for Lung Surgery scale and were assessed preoperatively at baseline, on postoperative day 1 (POD1) 1 to POD4, and then weekly until the fourth week. A random forest machine learning prediction model was built to rank the importance of each PRO score of patients on POD1 to POD4. We then selected the top 10 variables in terms of importance for the multivariable logistic regression analysis. Finally, a nomogram was developed. Results PROs, including coughing (POD3 and POD4), daily activity (POD1), and pain (POD1 and POD2), were associated with postdischarge complications in patients undergoing lung tumor surgery. The predictive model showed good performance in estimating the risk of postdischarge complications, with an area under the curve of 0.833 (95% confidence interval: 0.753–0.912), while maintaining good calibration and clinical value. Conclusion We found that PRO scores on POD1 to POD4 were associated with postdischarge complications after lung tumor surgery, and we developed a helpful nomogram model to predict the risk of postdischarge complications.
- Open Access
- 13 October 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (10) , 7645-7654
Postoperative Patient-Reported Outcomes after Uniportal Video-Assisted Thoracoscopic Surgery Using the Perioperative Symptom Assessment for Lung Surgery Scale
This study aimed to use a new special inventory for lung surgery patients to evaluate postoperative symptoms and functional status and to identify factors that may affect these after uniportal video-assisted thoracoscopic surgery (VATS). In this single-center longitudinal cohort observational study, we used a new scale, the perioperative symptom assessment for lung surgery (PSA-Lung), to evaluate the recovery from symptoms and the functional status of patients undergoing uniportal VATS. We divided patients into two groups, according to patients’ symptom scores, and compared the clinical characteristics between the two groups under each item. Then, we conducted a qualitative interview regarding coughing in postoperative week 4. Exactly 104 patients were enrolled in this study. The two highest-scoring patient-reported outcome (PRO) items were “shortness of breath” and “coughing” in the fourth week after surgery. Thirty-one patients reported that “coughing” severely influenced their lives in postoperative week 4. Using the PSA-Lung inventory, we found that “shortness of breath” was the worst symptom in postoperative week 4. Although “coughing” was not the most important symptom in the early postoperative period, it affected some patients’ lives in postoperative week 4. Therefore, further research is required to determine the optimal cut-off point for coughing.
- 13 October 2022
- Published by MDPI AG in Current Oncology
- Vol. 29 (10) , 7645-7654
Open AccessPostoperative Patient-Reported Outcomes after Uniportal Video-Assisted Thoracoscopic Surgery Using the Perioperative Symptom Assessment for Lung Surgery Scale
This study aimed to use a new special inventory for lung surgery patients to evaluate postoperative symptoms and functional status and to identify factors that may affect these after uniportal video-assisted thoracoscopic surgery (VATS). In this single-center longitudinal cohort observational study, we used a new scale, the perioperative symptom assessment for lung surgery (PSA-Lung), to evaluate the recovery from symptoms and the functional status of patients undergoing uniportal VATS. We divided patients into two groups, according to patients’ symptom scores, and compared the clinical characteristics between the two groups under each item. Then, we conducted a qualitative interview regarding coughing in postoperative week 4. Exactly 104 patients were enrolled in this study. The two highest-scoring patient-reported outcome (PRO) items were “shortness of breath” and “coughing” in the fourth week after surgery. Thirty-one patients reported that “coughing” severely influenced their lives in postoperative week 4. Using the PSA-Lung inventory, we found that “shortness of breath” was the worst symptom in postoperative week 4. Although “coughing” was not the most important symptom in the early postoperative period, it affected some patients’ lives in postoperative week 4. Therefore, further research is required to determine the optimal cut-off point for coughing.